Clinical Trials Logo

Clinical Trial Summary

The delayed administration of an adequate antimicrobial therapy is a strong predictor of impaired outcome in patients with bacterial sepsis. Therefore, the current Surviving Sepsis Campaign guidelines (2016) recommend that administration of intravenous antimicrobials be initiated within one hour following the recognition of sepsis or septic shock.

The quick Sepsis-related Organ Failure Assessment (qSOFA) score is a new bedside tool which has been recently proposed by the Third International Sepsis Consensus Definitions Task Force (Sepsis-3) to identify patients with suspected infection who are at greater risk for a poor outcome outside the Intensive Care Unit (ICU). It uses three criteria, assigning one point for low systolic blood pressure (SBP ≤100 mmHg), high respiratory rate (≥22 breaths per min) and altered mentation (Glasgow coma scale <15). The score ranges from 0 to 3 points. A qSOFA value ≥2 points is associated with a greater risk of death or prolonged ICU stay, these outcomes being more common in infected patients who may be septic than in those with uncomplicated infection. The definite goal of qSOFA is to hasten the management and thus improve the outcome of patients at risk of sepsis or septic shock.

Many patients admitted to the hospital for bacterial sepsis or septic shock are initially managed in the Emergency Department (ED). This study aims at investigating whether the routine calculation of qSOFA at patient triage may hasten the initiation of antimicrobial therapy in patients admitted to the ED with suspected or proven bacterial infection, especially in those with subsequent criteria for sepsis or septic shock (Sepsis-3 definition).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03299894
Study type Interventional
Source Centre Hospitalier Régional d'Orléans
Contact
Status Completed
Phase N/A
Start date October 12, 2017
Completion date June 10, 2018

See also
  Status Clinical Trial Phase
Completed NCT00487097 - The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients N/A
Completed NCT01997931 - The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients N/A
Recruiting NCT04926220 - Dynamic Estimation of Cardiac Output in the Operating Room
Not yet recruiting NCT03617796 - Prognostic Value of CD64 Marker for Patients in Intensive Care Unit
Withdrawn NCT04554264 - Complicated Grief in ICU in the Aftermath of COVID-19 N/A
Recruiting NCT02587273 - The Pharmacokinetics of Fentanyl in Intensive Care Patients Phase 4
Withdrawn NCT01749488 - The Impact of a Dietitian in the Implementation of Nutrition Recommendations During Intensive Care N/A
Recruiting NCT06110390 - High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients N/A
Completed NCT04186611 - Early Occupational Therapy in Intensive Care: Feasibility of Implementation N/A
Recruiting NCT03777150 - Is There a Benefit of Postoperative ICU Management After Elective Surgery in Critical Ill Patients? N/A
Completed NCT02583321 - Detection of Chlorhexidine in Tracheal Secretions After Routine Oral Care With Chlorhexidine Gluconate N/A
Completed NCT00787098 - Investigating Modes of Progressive Mobility Phase 2
Recruiting NCT04114747 - Renal Physiology During Continuous Renal Replacement Therapy N/A
Completed NCT02476591 - Charge Transparency in Critical Care Practice and Its Effects on Overall Cost of Care N/A
Completed NCT05795777 - Examination of the Pressure Ulcers in Intensive Care Patients.
Terminated NCT02587130 - Ketamine and Refractory Painful Care in a Palliative Unit Phase 4
Completed NCT02463123 - Energy Expenditure Estimation in Cardiac Surgery N/A
Completed NCT01607723 - "NAVA-PAV" Study: a Cross-over Comparative Study of 2 Advanced Modes Phase 3
Completed NCT01346813 - Epidemiology of Painful Procedures in Neonates N/A
Completed NCT00410852 - Efficacy and Safety of Three Insulin Protocols in Medical Intensive Care Unit Patients N/A